Most Read Articles
Jairia Dela Cruz, 10 Apr 2019
Treatment with tofacitinib yields significant improvements in signs and symptoms of rheumatoid arthritis (RA) in patients from the Asia Pacific, according to data from a posthoc analysis. The drug has a safety profile consistent with global tofacitinib studies, although infections occur more frequently in Asians.
Jairia Dela Cruz, 30 Apr 2019
In rheumatoid arthritis (RA) patients in remission, increasing the dose interval of tocilizumab injection from the standard 162 mg once weekly to twice weekly may do more harm than good. Specifically, such a strategy is associated with a lower chance of remission maintenance as well as a lack of improvement in tolerability, as shown in a recent trial.
Jairia Dela Cruz, 29 Apr 2019
Physicians are likely to underestimate the severity of psoriatic arthritis (PsA) in patients who are older, show higher fatigue levels, complain of greater pain or have poorer mental health, according to a Singapore study. In contrast, overestimation of disease severity by physicians tends to occur in the presence of higher swollen joint counts.
Jairia Dela Cruz, 05 Jan 2017
Patients with early arthritis should be allowed to share in the decision making regarding the approach to treatment, with rheumatologists acting as the primary specialists, according to the 2016 update of the European League Against Rheumatism (EULAR) recommendations for early arthritis management.

Elastic band resistance training improves muscle mass, physical function in older females

10 Feb 2018

Elastic band resistance training (ERT) is associated with improvements in muscle mass, physical function and muscle quality in elderly females, a recent study has shown.

Researchers randomized 56 elderly females (mean age 67.3±5.1 years) to receive 12 weeks of ERT (n=33) or a no-exercise control intervention (n=23). Lean mass, physical capacity and quality of life were assessed at baseline and at 3- and 9-month follow-up.

Relative to the controls, the ERT intervention resulted in significant improvements in appendicular lean mass at the 3-month (adjusted mean difference [MD], 0.99; 95 percent CI, 0.33–1.66; p<0.01) but not at the 9-month (adjusted MD, 0.49; –0.05 to 1.04) follow-up.

Appendicular mass index was significantly improved at both the 3-month (adjusted MD, 0.31; 0.03–0.61) and 9-month (adjusted MD, 0.21; 0.01–0.42; p<0.05 for both) follow-up. Total skeletal mass also significantly increased at both 3- and 9-month follow-up (adjusted MD, 0.70; 0.12–1.28; p<0.05 and adjusted MD, 0.72; 0.21–1.23; p<0.01, respectively).

The ERT intervention also improved physical capacity. At the 3-month follow-up, those who received the ERT walked faster by 0.14 m/s and reached further by 7.46 cm compared with controls. Both measures reached statistical significance (p<0.05 and p<0.001).

In the single leg stance test, balance was significantly greater by 9.71 s (p<0.001) in the ERT group. Scores in the Timed Up & Go test also improved significantly by 1.64 s (p<0.001).

The ERT group also showed significant improvements from baseline in the Medical Outcomes Study Short Form-36 Questionnaire scores at both the 3-month (MD, 13.00; 5.03–20.98; p<0.01) and 9-month (MD, 13.62; 6.47–20.76; p<0.001) follow-up.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 10 Apr 2019
Treatment with tofacitinib yields significant improvements in signs and symptoms of rheumatoid arthritis (RA) in patients from the Asia Pacific, according to data from a posthoc analysis. The drug has a safety profile consistent with global tofacitinib studies, although infections occur more frequently in Asians.
Jairia Dela Cruz, 30 Apr 2019
In rheumatoid arthritis (RA) patients in remission, increasing the dose interval of tocilizumab injection from the standard 162 mg once weekly to twice weekly may do more harm than good. Specifically, such a strategy is associated with a lower chance of remission maintenance as well as a lack of improvement in tolerability, as shown in a recent trial.
Jairia Dela Cruz, 29 Apr 2019
Physicians are likely to underestimate the severity of psoriatic arthritis (PsA) in patients who are older, show higher fatigue levels, complain of greater pain or have poorer mental health, according to a Singapore study. In contrast, overestimation of disease severity by physicians tends to occur in the presence of higher swollen joint counts.
Jairia Dela Cruz, 05 Jan 2017
Patients with early arthritis should be allowed to share in the decision making regarding the approach to treatment, with rheumatologists acting as the primary specialists, according to the 2016 update of the European League Against Rheumatism (EULAR) recommendations for early arthritis management.